Skip to content
POM-V Prescription Required Companion Animal

Lemicam 2.5 mg Chewable Tablets for Dogs

Active ingredient: Meloxicam

Form

Chewable

Species

Dogs

Manufacturer

Felix Pharmaceuticals PVT Limited

VMD MA No.

53540/5001

What it's used for

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Meloxicam

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Lemicam 2.5 mg Chewable Tablets for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 26 Mar 2026.

Alleviation of inflammation and pain in both acute and chronic musculo-skeletal
disorders in dogs.
Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first
day, which can be given orally or alternatively using Meloxicam 5 mg/ml solution for
injection for dogs and cats.
Treatment is to be continued once daily by oral administration (at 24-hour intervals)
at a maintenance dose of 0.1 mg meloxicam/kg body weight.
Each chewable tablet contains 2.5 mg meloxicam, which corresponds to the daily
maintenance dose for a 25 kg body weight dog respectively.
Each chewable tablet can be halved for accurate dosing according to the individual
body weight of the dog. Meloxicam chewable tablets can be administered with or
without food, are flavoured and are taken by most dogs voluntarily.
Dose scheme for the maintenance dose:
Number of chewable tablets
Body weight (kg)
1 mg2.5 mg
mg/kg
4.0–7.0½0.13–0.17.1–10.010.14–0.110.1–15.01½0.15–0.115.1–20.020.13–0.120.1–25.01 0.12–0.125.1–35.01½0.15–0.135.1–50.02 0.14–0.1
The use of Meloxicam oral suspension for dogs may be considered for an even more
precise dosing. For dogs weighing less than 4 kg the use of Meloxicam oral
suspension for dogs is recommended.
A clinical response is normally seen within 3–4 days. Treatment should be
discontinued after 10 days if no clinical improvement is apparent.

Issued: August 2022
AN: 00164/2021
Do not use in pregnant or lactating animals.
Do not use in dogs suffering from gastrointestinal disorders such as irritation and
haemorrhage, impaired hepatic, cardiac or renal function and haemorrhagic
disorders.
Do not use in dogs less than 6 weeks of age or less than 4 kg body weight.
Do not use in cases of hypersensitivity to the active substance or to any of the
excipients.
Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea,
faecal occult blood, lethargy and renal failure have very rarely been reported from
post-marketing safety experience.
Very rare cases of haemorrhagic diarrhoea, haematemesis, gastrointestinal
ulceration and elevated liver enzymes have been reported from post-marketing
safety experience.
These side effects occur generally within the first treatment week and are in most
cases transient and disappear following termination of the treatment but in very rare
cases may be serious or fatal.
If adverse reactions occur, treatment should be discontinued and the advice of a
veterinarian should be sought.
The frequency of adverse reactions is defined using the following convention:
-
-
-
-
-
None.

Issued: August 2022
AN: 00164/2021

Special precautions for use in animals
Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a
potential risk of renal toxicity.
This product for dogs should not be used in cats as it is not suitable for use in this
species. In cats, Meloxicam 0.5 mg/ml oral suspension for cats should be used.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to non-steroidal anti-inflammatory drugs
(NSAIDs) should avoid contact with the product.
Accidental ingestion of the product by a child may cause gastro-intestinal effects,
such as nausea and gastric pain.
Any uneaten medicated food must be disposed of immediately and the bowl washed
thoroughly.
Return part-used tablets into the blister and carton.
In case of accidental ingestion, seek medical advice immediately and show the
package leaflet or the label to the physician.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances
with high protein binding may compete for binding and thus lead to toxic effects.
Meloxicam must not be administered in conjunction with other NSAIDs or
glucocorticosteroids.
Pre-treatment with anti-inflammatory substances may result in additional or
increased adverse effects and accordingly a treatment-free period with such
veterinary medicinal products should be observed for at least 24 hours before
commencement of treatment. The treatment-free period, however, should take into
account the pharmacological properties of the products used previously.
This veterinary medicinal product does not require any special storage conditions.
Unused tablet halves should be stored in the blister and given at the next
administration.
The use of Meloxicam oral suspension for dogs may be considered for an even more
precise dosing. For dogs weighing less than 4 kg the use of Meloxicam oral
suspension for dogs is recommended.
A clinical response is normally seen within 3–4 days. Treatment should be
discontinued after 10 days if no clinical improvement is apparent.

Issued: August 2022
AN: 00164/2021
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
In case of overdose symptomatic treatment should be initiated.
4.11 Withdrawal period(s)
Not applicable.
5.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.